- March 2025: The stock traded around $12.60 levels as the company began implementing its transformation strategy
- May 2025: Prices reached approximately $12.64 following better-than-expected Q1 results
- June 2025: Moderate decline to $12.14 as market sentiment shifted
- August 2025: Current levels around $11.94 represent a consolidation phase
How to Buy Avanos Medical, Inc. (AVNS) Shares - Investment in Avanos Medical, Inc. (AVNS) Stock
Updated on 01 Sep 2025
Thinking about investing in medical innovation that touches lives daily? Avanos Medical represents the cutting edge of healthcare technology, specializing in pain management and nutritional solutions that help patients recover faster. With the aging population driving healthcare demand, this company sits at the intersection of medical necessity and technological advancement—making it an intriguing opportunity for forward-thinking investors.
Article navigation
- 📈 Current Market Position and Entry Strategy
- 🔄 6-Month Price Journey and Trend Analysis
- 🔮 Price Forecast: 2025-2030 Outlook
- ⚠️ Risk Assessment: What Could Go Wrong?
- 🟢 Positive Signals: Why Investors Are Optimistic
- 🛡️ Beginner Trader Action Plan Today
- ✅ How to Buy Avanos Medical, Inc. (AVNS) Shares – Step by Step
- 💡 Why Pocket Option Appeals to New Investors
- 🌍 Avanos Medical in 2025: Healthcare Innovation Leader
📈 Current Market Position and Entry Strategy
As of September 1, 2025, Avanos Medical (AVNS) shares trade at $11.94, presenting what many analysts consider an attractive entry point for long-term investors. The stock has experienced significant volatility throughout 2025 but currently sits at levels that could offer substantial upside potential for patient investors.
Critical Date Alert: Mark your calendar for October 29, 2025—this is when Avanos releases its Q3 earnings report. Historically, earnings announcements have created significant price movements. The previous Q2 report on August 5, 2025, showed revenue beating expectations at $175 million (MarketBeat Earnings Data), though EPS slightly missed estimates.
Historical Earnings Impact Analysis
Looking at recent quarterly performance reveals a pattern worth noting:
| Quarter | EPS Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Price Impact |
|---|---|---|---|---|---|
| Q2 2025 | $0.18 | $0.17 | $165.5M | $175.0M | Mixed reaction |
| Q1 2025 | $0.18 | $0.26 | – | – | +44% surprise |
| Q4 2024 | $0.40 | $0.43 | – | – | +7.5% beat |
The pattern suggests that while revenue performance has been strong, earnings consistency remains a challenge. However, the company’s ability to exceed revenue expectations indicates underlying business strength.
🔄 6-Month Price Journey and Trend Analysis
Avanos Medical shares have navigated turbulent waters over the past six months, presenting both challenges and opportunities:
The overall trend shows a 5.5% decline from March peaks, but this must be viewed in context of the broader healthcare sector challenges and the company’s strategic repositioning.
Key drivers behind this performance include:
- Successful implementation of cost management initiatives
- Organizational restructuring efforts
- Expansion of direct operations in key markets like the UK
- Ongoing portfolio transformation toward higher-margin products
🔮 Price Forecast: 2025-2030 Outlook
Based on current analyst projections and company fundamentals, here’s what investors might expect:
- 2025 Year-End: $12.50-$13.50 range → BUY recommendation for long-term holders
The company’s guidance of $665-685 million revenue for 2025 suggests stability, while cost containment measures should improve margins - 2026 Projection: $14.00-$16.00
Analysts at Moomoo project average 12-month targets around $14.00, with more optimistic forecasts reaching $17.34 - 2028 Outlook: $18.00-$22.00
Assuming successful execution of transformation strategy and market expansion - 2030 Vision: $25.00+ potential
Long-term demographic trends in healthcare spending support sustained growth
The investment thesis hinges on Avanos successfully executing its transformation strategy while capitalizing on aging population trends and increased healthcare spending.
⚠️ Risk Assessment: What Could Go Wrong?
Every investment carries risks, and Avanos Medical presents several important considerations:
- Regulatory Risks: Healthcare remains heavily regulated, with changes potentially impacting product approvals and reimbursement rates
- Financial Challenges: The company reported a $76.8 million net loss in Q2 2025 due to impairment charges (AInvest Report)
- Competitive Pressure: Medical device industry competition intensifies constantly
- Execution Risk: Transformation strategies don’t always deliver expected results
However, these risks must be balanced against the company’s strong market positions and growing demand for its specialized medical solutions.
🟢 Positive Signals: Why Investors Are Optimistic
Several factors suggest Avanos Medical could be poised for recovery:
- UK Expansion Success: The July 2025 transition to direct operations for MIC-KEY products (Company Announcement) should improve margins and customer relationships
- Revenue Stability: Q2 2025 sales grew 1.9% year-over-year to $175 million
- Market Leadership: Strong positions in enteral feeding and non-opioid pain management
- Transformation Progress: Cost management and organizational restructuring showing early results
🛡️ Beginner Trader Action Plan Today
Based on current analysis, here’s what makes sense for new investors:
- Start Small: Begin with a position representing no more than 2-3% of your portfolio
- Dollar-Cost Average: Consider building your position gradually rather than one large purchase
- Set Price Alerts: Monitor for opportunities below $11.50 for better entry points
- Long-Term Mindset: This investment requires patience—think in terms of years, not months
Humorous veteran trader wisdom: “Trading AVNS is like medical recovery—sometimes you need to endure short-term pain for long-term gain. Just don’t try to perform surgery without proper training!”
✅ How to Buy Avanos Medical, Inc. (AVNS) Shares – Step by Step
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Choose a Trading Platform | Ensure it offers NYSE access and reasonable commission rates |
| 2 | Complete Account Funding | Start with an amount you’re comfortable potentially losing |
| 3 | Search for “AVNS” | Use the ticker symbol, not just the company name |
| 4 | Select Order Type | Use limit orders to control your entry price |
| 5 | Review and Confirm | Double-check order details before finalizing |
💡 Why Pocket Option Appeals to New Investors
For those beginning their investment journey, Pocket Option offers several advantages that make entering the market less intimidating:
- Minimal Entry Barrier: With a $5 minimum deposit, you can test strategies without significant financial commitment
- Rapid Verification: The 1-minute KYC process using any single document means you can start trading almost immediately
- Diverse Withdrawal Options: Over 100 methods including cryptocurrencies, e-wallets, and traditional banking options provide flexibility
The platform’s user-friendly interface combined with low entry requirements makes it ideal for investors wanting to build positions in companies like Avanos Medical gradually.
🌍 Avanos Medical in 2025: Healthcare Innovation Leader
Avanos Medical stands as a significant player in the global medical technology landscape, specializing in two critical areas: Chronic Care and Pain Management. The company develops innovative solutions that help patients transition from hospital to home care while reducing opioid dependence through non-narcotic pain management technologies.
The company’s product portfolio includes:
- Enteral feeding systems providing vital nutrition support
- Radiofrequency ablation equipment for pain management
- Surgical recovery solutions enhancing patient outcomes
- Neonatal intensive care products for vulnerable newborns
With operations spanning the United States, Europe, and Asia, Avanos maintains a global footprint while focusing on high-margin specialty products that address unmet medical needs.
Interesting Fact 2025: Avanos made headlines by ending a 29-year distribution partnership to take direct control of its UK operations—a bold move that demonstrates confidence in their products and commitment to customer relationships. This strategic shift began July 25, 2025, and represents the company’s aggressive approach to market expansion.
FAQ
What makes Avanos Medical different from other healthcare stocks?
Avanos focuses on specialized medical devices in high-growth areas like non-opioid pain management and enteral feeding, rather than competing in crowded pharmaceutical markets.
How often does Avanos pay dividends?
The company currently does not pay dividends, preferring to reinvest profits into growth initiatives and product development.
What's the biggest risk for AVNS investors?
Execution risk on their transformation strategy and regulatory changes in healthcare reimbursement policies pose significant challenges.
Should I buy before or after earnings reports?
Historical patterns suggest potential opportunities both ways—before if you expect positive surprises, after if you prefer to avoid earnings volatility.
How does the aging population affect Avanos?
Demographic trends strongly favor companies providing medical devices for chronic conditions and surgical recovery, positioning Avanos well for long-term growth.
Signals
Sign up for more like this
Customize your newsfeed with content you're actually interested in — get up-to-date personalized newsletter in your inbox.
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.